Alteogen Inc. signed its first billion-dollar partnership this year for ALT-B4 technology through two separate contracts with Astrazeneca plc’s U.K.- and U.S.-based Medimmune subsidiaries worth up to $1.35 billion combined.
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example of government waste as spending $8 million on “making mice transgender. This is real.” Skeptical media outlets jumped on the case right away.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Lundbeck, Otsuka, Springworks, Zai Lab.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blue Earth, Cosciens, Ennodc, Grifols, Merck, Rivus, Shionogi, Transcode, UCB.
Cardiothoracic surgeon and television personality Mehmet Oz, President Donald Trump’s nominee for administrator of the Centers for Medicare & Medicaid Services (CMS), faced the U.S. Senate’s finance committee on March 14, suggesting the implementation of artificial intelligence (AI) technologies and the reduction of drug prices would be among his top priorities, if confirmed.
RSS
